ARTICLES
Venn Life Sciences Holdings acquires assets of Evocutis
February 27, 2014
FDA approves Myalept to treat rare metabolic disease
February 26, 2014
TeraDiscoveries, Egenix partner for cancer, autism drugs
February 26, 2014
Dystonia Europe, EPDA partner with Boston Scientific
February 26, 2014